CVS HEALTH CORPORATION — Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR

Next earnings (estimated): Wed, April 1, 2026 30 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-12-31$105.69B↑+8.2%$2.94B↑+79.0%2.0%
2025-09-30$102.87B↑+7.8%$-3.98B↓-4669.0%-3.1%
2025-06-30$98.92B↑+8.4%$1.01B↓-42.7%2.4%
2025-03-31$94.59B↑+7.0%$1.78B↑+58.5%3.6%
2024-12-31$97.71B↑+4.2%$1.64B↓-19.6%2.4%
2024-09-30$95.43B↑+6.3%$87M↓-96.2%0.9%
2024-06-30$91.23B↑+2.6%$1.77B↓-7.6%3.3%
2024-03-31$88.44B↑+3.7%$1.12B↓-47.5%2.6%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q4)

Revenue
$105.69B
↑+8.2% +$7.98B YoY
Net Income
$1.35B
↓-17.6% -$290M YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 74 quarters

margin trajectory tells the operating-leverage story
Gross Margin
15.4%
Operating Margin↓-0.4pts
2.0%
Net Margin↑+1.1pts
2.8%

Go deeper